Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription Articles published in J Med Virol Retrieve available abstracts of 138 articles: HTML format

Single Articles

September 2025
1. BERTONI C, Diotallevi S, Lolatto R, Piromalli G, et al
   Hepatitis B Viral Rebound in People With HIV Under HBV-Active Antiretroviral Therapy.
   J Med Virol. 2025;97:e70573.
   PubMed     Abstract available
   
   
   
2. KIM H, Kim JY, Choi HB, Lee JS, et al
   Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent.
   J Med Virol. 2025;97:e70584.
   PubMed     Abstract available
   
   
   
3. ZHONG S, Zeng Z, Jin Z, Zhang L, et al
   Single-Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7(+) Subset Linked to Antiviral Potential in Chronic HBV Infection.
   J Med Virol. 2025;97:e70572.
   PubMed     Abstract available
   
   
   
4. YAN B, Lv J, Feng Y, Yin W, et al
   Epidemiology and Genetic Surveillance of Human Hepatitis E Virus Infections in Shandong Province, Eastern China, 2019-2023.
   J Med Virol. 2025;97:e70595.
   PubMed     Abstract available
   
   
   August 2025
5. ZHANG J, Qu C, Zhang Y, Guan G, et al
   AUF1 Is a Novel Negative Regulator for Hepatitis B Virus Replication Acting Through a Posttranscriptional Manner.
   J Med Virol. 2025;97:e70505.
   PubMed     Abstract available
   
   
   
6. WANG X, Ren N, Liu H, Xie J, et al
   Global Disease and Economic Burden of Noncommunicable Diseases Attributable to Hepatitis B Infection: A Health Economic Evaluation Study.
   J Med Virol. 2025;97:e70519.
   PubMed     Abstract available
   
   
   
7. KHOUNVISITH V, Odermatt P, Virachith S, Innoula N, et al
   Hepatitis A and E Virus Seroprevalence and Water, Sanitation and Hygiene Levels in Rural Areas of Khammouane Province, Lao People's Democratic Republic: A Cross-Sectional Study.
   J Med Virol. 2025;97:e70524.
   PubMed     Abstract available
   
   
   
8. LI S, Li S, Cheng Y, Liu J, et al
   Bacterial Co-Infection Delays Hepatitis B Virus Clearance in a Chronic Replication Mouse Model by Inducing T Cell Exhaustion.
   J Med Virol. 2025;97:e70516.
   PubMed     Abstract available
   
   
   
9. LUO P, Chen N, Tang Y, Wang J, et al
   Paternally Expressed Gene 10 Promoter Methylation Level as a Predictor of HBeAg Seroconversion in Chronic Hepatitis B Patients.
   J Med Virol. 2025;97:e70510.
   PubMed     Abstract available
   
   
   
10. LIU M, Zhang X, Xu Z
    Cross-Country Inequalities in Hepatitis E Virus Infection From 1990 to 2021: A Brief Analytical Insights From the Global Burden of Disease Study 2021.
    J Med Virol. 2025;97:e70560.
    PubMed    
    
    
    
11. HU Q, Han J, Chen C, Tao S, et al
    Circulating Cell-Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV-Related Acute-on-Chronic Liver Failure.
    J Med Virol. 2025;97:e70551.
    PubMed     Abstract available
    
    
    July 2025
12. PANG X, He Q, Huang J, Tang K, et al
    Epidemiological Trends and CD4+T Cell Recovery in HIV-1 Patients With HCV/HBV Co-Infection: A Retrospective Cohort Study in Southwest China (2003-2024).
    J Med Virol. 2025;97:e70465.
    PubMed     Abstract available
    
    
    
13. ZHANG Y, Pan H, Zhao X, Yi H, et al
    The Impact of HPV/HBV Coinfection on Cervical Cancer Risk: Potential Mediating Role of Ki67.
    J Med Virol. 2025;97:e70454.
    PubMed     Abstract available
    
    
    
14. DIMEGLIO C, El Rakaawi M, Boineau J, De Smet C, et al
    Increase in HEV IgG Seroprevalence During the Past Years in Southern France.
    J Med Virol. 2025;97:e70483.
    PubMed     Abstract available
    
    
    
15. KLUTSCH S, Boschi C, Motte A, Halfon P, et al
    Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient.
    J Med Virol. 2025;97:e70480.
    PubMed     Abstract available
    
    
    June 2025
16. LAMPEJO T
    Hepatitis E Virus Persistence in Sanctuary Sites and Its Potential Role in Relapse.
    J Med Virol. 2025;97:e70444.
    PubMed    
    
    
    
17. MISRA G, Gupta M, Singhal R, Qaisar S, et al
    Strategic Approach to Enhancing Diagnostic Precision: Optimizing Panel Size for HBV and HCV Viral Load Monitoring Kits.
    J Med Virol. 2025;97:e70437.
    PubMed     Abstract available
    
    
    
18. DE OLIVEIRA KG, Vasconcelos MPA, Ton JT, Uehara SNO, et al
    A Comprehensive Molecular and Serological Investigation of Hepatitis A Virus Among Patients With Suspected Acute Hepatitis: A Brazilian Study.
    J Med Virol. 2025;97:e70449.
    PubMed     Abstract available
    
    
    May 2025
19. XU X, Zhang Y, Wu S, Wu Y, et al
    Hepatitis B Virus Promotes Angiogenesis in Hepatocellular Carcinoma by Increasing m6A Modification of VEGFA mRNA via IGF2BP3.
    J Med Virol. 2025;97:e70356.
    PubMed     Abstract available
    
    
    
20. HUANG L, Ye B, Cao F, Ruan B, et al
    Single-Cell Atlas of the Peripheral Immune Response in Patients With Chronic Hepatitis B.
    J Med Virol. 2025;97:e70360.
    PubMed     Abstract available
    
    
    
21. KILLER A, Gliga S, Jensen BO, Park P, et al
    Functional Cure of Hepatitis B and D Coinfection After ART Nonadherence in a Person With HIV.
    J Med Virol. 2025;97:e70375.
    PubMed    
    
    
    
22. YE X, Xu X, Dang Y, Zeng J, et al
    High Genetic Variability of Hepatitis B Virus in Blood Donors With Surface Antigen Positive But DNA Negative in Southern China.
    J Med Virol. 2025;97:e70396.
    PubMed     Abstract available
    
    
    
23. MAO T, Du X, Li Y, Zhou Z, et al
    DNAJC9 Binds to and Enhances the Transcription of Hepatitis B Virus cccDNA by Recruiting Histone H3.3.
    J Med Virol. 2025;97:e70390.
    PubMed     Abstract available
    
    
    
24. SANTOS-SILVA S, Lois M, Machado A, Bordalo A, et al
    Environmental Surveillance of Hepatitis E Virus and Rat Hepatitis E Virus in Portugal and Spain, 2020-2022.
    J Med Virol. 2025;97:e70414.
    PubMed     Abstract available
    
    
    
25. ELIZALDE MM, Monzani MC, Favale NO, Bouzas B, et al
    Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg-Negative Stage of Chronic Hepatitis B.
    J Med Virol. 2025;97:e70398.
    PubMed     Abstract available
    
    
    
26. YOU Q, Wang K, Zhao Z, Zhou H, et al
    Reduction of Bacteroides fragilis in Gut Microbiome of Chronic Hepatitis B Patients Promotes Liver Injury.
    J Med Virol. 2025;97:e70395.
    PubMed     Abstract available
    
    
    April 2025
27. FANG Z, Wang C, Huang CL, Tan D, et al
    Extrathymic CD8 and CD4 Double Positive T Cells Presenting Vigorous HBV-Specific Responses Accelerate HBV Clearance.
    J Med Virol. 2025;97:e70303.
    PubMed     Abstract available
    
    
    
28. WAN Q, Yu X, Huang J, Yang L, et al
    An Investigative Study of LGALSL and HLA-DRB1 as Prognostic Biomarkers and Therapeutic Targets in Chronic Hepatitis B Patients With Persistent HBV DNA Viremia Under Entecavir Treatment.
    J Med Virol. 2025;97:e70329.
    PubMed     Abstract available
    
    
    
29. YE L, Ouyang W, Gu Y, Yao Z, et al
    HBcrAg Dynamic Change During Treatment Predicts HBsAg Loss in Pediatric Patients With Chronic Hepatitis B.
    J Med Virol. 2025;97:e70350.
    PubMed     Abstract available
    
    
    
30. HSU PY, Su HC, Ma MC, Chen CA, et al
    Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B Patients: Systematic Review and Meta-Analysis.
    J Med Virol. 2025;97:e70331.
    PubMed     Abstract available
    
    
    
31. DENG Y, Zheng J, Li F, Zou H, et al
    Hepatocyte-Enriched miRNA-193b-3p Promotes Hepatitis B Virus Replication by Dual Activation of Viral Core Promoter Activity and Autophagy Induction by Targeting IGF-1R.
    J Med Virol. 2025;97:e70330.
    PubMed     Abstract available
    
    
    March 2025
32. WU BY, Tian YX, Zuo J, Yang JR, et al
    Global, Regional, and National Burdens of Hepatitis E From 1990 to 2021 and Predicted 2030 Incidence: Results From the Global Burden of Disease Study 2021.
    J Med Virol. 2025;97:e70279.
    PubMed     Abstract available
    
    
    
33. JIANG Q, Zhou Z, Du X, Li Y, et al
    Novel Function of NUP153 in HNF4alpha Transcriptional Upregulation Contributes to Promoting HBV Replication.
    J Med Virol. 2025;97:e70256.
    PubMed     Abstract available
    
    
    
34. MIAO X, Zhou X, Liu C, Shi H, et al
    Alcohol-Induced Dendritic Cells and Their Exosomes Promote T-Cell Immunity in Hepatitis B Virus Transgenic Mice and Patients With Chronic Hepatitis B.
    J Med Virol. 2025;97:e70287.
    PubMed     Abstract available
    
    
    
35. JIN Q, Zhou M, Sun M, Ning B, et al
    Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021 Data.
    J Med Virol. 2025;97:e70283.
    PubMed     Abstract available
    
    
    
36. LIU HN, Lin SY, Ramirez R, Chen SE, et al
    Development of an NGS-Based Estimation of Integrated HBV DNA in Liver Biopsies and Detection in Liquid Biopsies.
    J Med Virol. 2025;97:e70290.
    PubMed     Abstract available
    
    
    
37. XIE ZQ, Tan WL, Wang ZM, Kang Y, et al
    HBx/DTL Positive Feedback Loop Promotes HBV-Related Hepatocellular Carcinoma Progression.
    J Med Virol. 2025;97:e70284.
    PubMed     Abstract available
    
    
    
38. CHIANG CM, Lin YJ, Liu WC, Chou TC, et al
    HBV Recurrence Detected by HBV-Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation.
    J Med Virol. 2025;97:e70306.
    PubMed     Abstract available
    
    
    
39. XIA W, Tan Y, Mei B, Zhou Y, et al
    Application of Interpretable Machine Learning Models to Predict the Risk Factors of HBV-Related Liver Cirrhosis in CHB Patients Based on Routine Clinical Data: A Retrospective Cohort Study.
    J Med Virol. 2025;97:e70302.
    PubMed     Abstract available
    
    
    
40. PONNUVEL S, Ali H, Prakash A, John Steve R, et al
    Superior Performance of Newly Developed Alinity Anti-HCV Next Assay in the Diagnosis of HCV Infection.
    J Med Virol. 2025;97:e70307.
    PubMed     Abstract available
    
    
    February 2025
41. LUZ E, Marques M, Arriaga MB, Campos LM, et al
    Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.
    J Med Virol. 2025;97:e70186.
    PubMed     Abstract available
    
    
    
42. LIU Q, Huang J, Hu J, Ding Y, et al
    The Effect of HBV Therapy on Glycemic Control in HBV-Infected Patients With Diabetes: A 90-day Multicenter Study.
    J Med Virol. 2025;97:e70185.
    PubMed     Abstract available
    
    
    
43. KIM LY, Kim JY, Yoo JJ, Kim SG, et al
    Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B.
    J Med Virol. 2025;97:e70187.
    PubMed     Abstract available
    
    
    
44. ZHANG F, Shi Z, Wu Y, Xia J, et al
    Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against Hepatitis E Virus Infection in Rabbits.
    J Med Virol. 2025;97:e70218.
    PubMed     Abstract available
    
    
    
45. CHOI YM, Kim DH, Cho EJ, Kim Z, et al
    The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced Viral Replication and Apoptotic Cell Death Induced by PERK-eIF2alpha-CHOP-Mediated ER Stress.
    J Med Virol. 2025;97:e70253.
    PubMed     Abstract available
    
    
    
46. ARSLAN N, Reuter B, Buech J, Lengauer T, et al
    Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning Methods.
    J Med Virol. 2025;97:e70169.
    PubMed     Abstract available
    
    
    January 2025
47. LIU M, Yuan M, Ma Y, Wang J, et al
    Wild-Type and rtA181T/sW172* Mutant Strains of Hepatitis B Virus Drive Hepatocarcinogenesis via Distinct GRP78-Mediated ER Stress Pathways.
    J Med Virol. 2025;97:e70151.
    PubMed     Abstract available
    
    
    
48. 
    Correction to "Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain".
    J Med Virol. 2025;97:e70152.
    PubMed    
    
    
    December 2024
49. FAN Z, Xu L, Cao Y, Liu T, et al
    One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing.
    J Med Virol. 2024;96:e70115.
    PubMed     Abstract available
    
    
    
50. KAMBOJ S, Kumar M
    Global Origin and Spatiotemporal Spread of Hepatitis C Virus Epidemic Genotypes/Subtypes: A Complete Genome-Based Phylodynamic and Phylogeographic Analyses.
    J Med Virol. 2024;96:e70123.
    PubMed     Abstract available
    
    
    
51. LI Z, Rahman N, Bi C, Mohallem R, et al
    RNA Helicase DDX5 in Association With IFI16 and the Polycomb Repressive Complex 2 Silences Transcription of the Hepatitis B Virus by Interferon.
    J Med Virol. 2024;96:e70118.
    PubMed     Abstract available
    
    
    
52. LIN W, He Y, Gu F, Hu F, et al
    Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV-1 Co-Infection.
    J Med Virol. 2024;96:e70114.
    PubMed     Abstract available
    
    
    
53. ZHANG Y, Luo Q, Lin X, Wang L, et al
    Development and Validation of a New Model Including Inflammation Indexes for the Long-Term Prognosis of Hepatitis B-Related Acute-On-Chronic Liver Failure.
    J Med Virol. 2024;96:e70110.
    PubMed     Abstract available
    
    
    November 2024
54. CHU D, Oh YH, Sung H, Ko DH, et al
    Simple, direct amplification of RNA-containing paper discs for diagnosing the hepatitis C virus.
    J Med Virol. 2024;96:e29919.
    PubMed     Abstract available
    
    
    
55. RIBEIRO LB, Reche LA, Nastri ACSS, Malta FM, et al
    Acute Hepatitis Related to Hepatitis E Virus Genotype 3f Infection in Brazil.
    J Med Virol. 2024;96:e70024.
    PubMed     Abstract available
    
    
    
56. HUANG D, Yuan Z, Wu D, Yuan W, et al
    HBV Antigen-Guided Switching Strategy From Nucleos(t)ide Analogue to Interferon: Avoid Virologic Breakthrough and Improve Functional Cure.
    J Med Virol. 2024;96:e70021.
    PubMed     Abstract available
    
    
    
57. GONG G, Xin J, Lou Y, Qiong D, et al
    Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain.
    J Med Virol. 2024;96:e70031.
    PubMed     Abstract available
    
    
    
58. DONG R, Xue H, Chen L, Jin W, et al
    Associations of Lipid Profiles With the Onset of HEV-Related Acute Liver Failure: A Multicenter Cohort Study.
    J Med Virol. 2024;96:e70033.
    PubMed     Abstract available
    
    
    
59. WANG J, Jiang H, Zhang G, Dai X, et al
    Real-World Pharmacovigilance Study Identifies Drugs Linked to Hepatitis B Virus Reactivation.
    J Med Virol. 2024;96:e70055.
    PubMed     Abstract available
    
    
    October 2024
60. MUTIMER D, Atabani SF, Brown M, Logan J, et al
    Determinants of HBeAg loss during follow-up of a multiethnic pediatric cohort.
    J Med Virol. 2024;96:e29936.
    PubMed     Abstract available
    
    
    
61. HE P, Li J, Wang C, Zhang J, et al
    Incidence and risk factors of de novo hepatitis E virus infection after receiving liver transplantation.
    J Med Virol. 2024;96:e29939.
    PubMed     Abstract available
    
    
    
62. TREVINO-NAKOURA A, Sepulveda-Crespo D, Bellon JM, Codina H, et al
    Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e70018.
    PubMed     Abstract available
    
    
    September 2024
63. CHEN J, Feng T, Xu Q, Yu X, et al
    Risk predictive model for the development of hepatocellular carcinoma before initiating long-term antiviral therapy in patients with chronic hepatitis B virus infection.
    J Med Virol. 2024;96:e29884.
    PubMed     Abstract available
    
    
    
64. LV Z, Liu L, You J, Zhou P, et al
    Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9.
    J Med Virol. 2024;96:e29894.
    PubMed     Abstract available
    
    
    
65. RZYMSKI P, Jibril AT, Rahmah L, Abarikwu SO, et al
    Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.
    J Med Virol. 2024;96:e29900.
    PubMed     Abstract available
    
    
    August 2024
66. SAKR AA, Mohamed AA, Ahmed AE, Abdelhaleem AA, et al
    Biochemical implication of acetylcholine, histamine, IL-18, and interferon-alpha as diagnostic biomarkers in hepatitis C virus, coronavirus disease 2019, and dual hepatitis C virus-coronavirus disease 2019 patients.
    J Med Virol. 2024;96:e29857.
    PubMed     Abstract available
    
    
    
67. LI X, Zhou Q, Lu Z, Huang R, et al
    Association of HLA-DRB1 alleles with status of antibodies to hepatitis B surface and e antigen.
    J Med Virol. 2024;96:e29867.
    PubMed     Abstract available
    
    
    
68. SU R, Yan L, Jiang B, Li J, et al
    A novel model based on serum N-glycan markers for evaluating stage of liver necroinflammation in treatment-naive chronic hepatitis B patients.
    J Med Virol. 2024;96:e29863.
    PubMed     Abstract available
    
    
    July 2024
69. SHIN H, Lim GS, Yoon JW, Ko Y, et al
    Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.
    J Med Virol. 2024;96:e29760.
    PubMed     Abstract available
    
    
    
70. LI Y, Zeng T, Huang P, Tan W, et al
    Investigating the role of killer cell immunoglobulin-like receptors and human leukocyte antigen genetic variants in hepatitis C virus infection.
    J Med Virol. 2024;96:e29776.
    PubMed     Abstract available
    
    
    
71. DENG H, Chen Y, Liang S, Liang X, et al
    Near full-length genome analysis of HEV 4b subtype in pigs showed a similarity up to 99.944% compared to a patient in Guangdong province, China.
    J Med Virol. 2024;96:e29777.
    PubMed     Abstract available
    
    
    
72. CASTRO V, Calvo G, Oliveros JC, Perez-Del-Pulgar S, et al
    Hepatitis C virus-induced differential transcriptional traits in host cells after persistent infection elimination by direct-acting antivirals in cell culture.
    J Med Virol. 2024;96:e29787.
    PubMed     Abstract available
    
    
    
73. SUZUKI T, Matsuura K, Inoue T, Sasada K, et al
    Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B Patients.
    J Med Virol. 2024;96:e29816.
    PubMed     Abstract available
    
    
    
74. ZENG Q, Ren Y, Wang Y, Yang J, et al
    The nuclear matrix protein HNRNPU restricts hepatitis B virus transcription by promoting OAS3-based activation of host innate immunity.
    J Med Virol. 2024;96:e29805.
    PubMed     Abstract available
    
    
    
75. SATAKE M, Sugiyama M, Mizokami M, Tanaka J, et al
    Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levels.
    J Med Virol. 2024;96:e29823.
    PubMed     Abstract available
    
    
    
76. SHEN L, Zhang Y, Shi M, Shao L, et al
    Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay.
    J Med Virol. 2024;96:e29817.
    PubMed     Abstract available
    
    
    June 2024
77. LI X, Sun X, Pinpin J, Zhao Q, et al
    Multifunctional ORF3 protein of hepatitis E virus.
    J Med Virol. 2024;96:e29691.
    PubMed     Abstract available
    
    
    
78. WEN X, Wu X, Sun Y, Zhou J, et al
    Long-term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB.
    J Med Virol. 2024;96:e29606.
    PubMed     Abstract available
    
    
    
79. FIGUEROA GB, D'souza S, Pereira HS, Vasudeva G, et al
    Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genome.
    J Med Virol. 2024;96:e29692.
    PubMed     Abstract available
    
    
    
80. ZHENG D, Cheng C, Tang Y, Fang Z, et al
    Circulating metabolites are associated with persistent elevations of ALT in patients with chronic hepatitis B with complete viral suppression.
    J Med Virol. 2024;96:e29723.
    PubMed     Abstract available
    
    
    
81. SCHEMMERER M, Bock HH, Schattenberg JM, Huber S, et al
    Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients.
    J Med Virol. 2024;96:e29735.
    PubMed     Abstract available
    
    
    
82. GUO JW, Ho HY, Dai CY, Chen YH, et al
    Single-tube, single-strip lateral flow assays utilizing loop-mediated isothermal amplification for simultaneous hepatitis B and C viral detection.
    J Med Virol. 2024;96:e29721.
    PubMed     Abstract available
    
    
    
83. LI G, Liu X, Lu F
    What is the real sword of HBV precore and basal core promoter mutations piercing the hepatocyte homeostasis: HBcAg or HBsAg?
    J Med Virol. 2024;96:e29745.
    PubMed    
    
    
    
84. GU F, Zeng K, Lan X, He Y, et al
    Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV-co-infected patients with HBsAg loss.
    J Med Virol. 2024;96:e29762.
    PubMed     Abstract available
    
    
    May 2024
85. WU L, Deng H, Feng X, Xie D, et al
    Interferon-gamma(+) Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization.
    J Med Virol. 2024;96:e29627.
    PubMed     Abstract available
    
    
    
86. PIRALLA A, Giardina F, Ferrari G, Gaiarsa S, et al
    Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates.
    J Med Virol. 2024;96:e29658.
    PubMed     Abstract available
    
    
    
87. LIANG Y, Zhang J, Luo D, Cheng L, et al
    Deregulation of immune response contributing to fulminant hepatitis in HEV infected pregnant women.
    J Med Virol. 2024;96:e29639.
    PubMed     Abstract available
    
    
    
88. LI Q, Wen W, Wang Y, Gong T, et al
    Autophagy-related protein 5 (ATG5) interacts with bone marrow stromal cell antigen 2 (BST2) to stimulate HBV replication through antagonizing the antiviral activity of BST2.
    J Med Virol. 2024;96:e29659.
    PubMed     Abstract available
    
    
    
89. LIU CH, Chang YP, Lee JY, Chen CY, et al
    Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
    J Med Virol. 2024;96:e29675.
    PubMed     Abstract available
    
    
    
90. TAN A, He Y, Zhou Y, Peng X, et al
    A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B.
    J Med Virol. 2024;96:e29661.
    PubMed     Abstract available
    
    
    
91. LAI X, OuYang W, Li S, Qiu J, et al
    Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg seroconversion in children with chronic hepatitis B.
    J Med Virol. 2024;96:e29670.
    PubMed     Abstract available
    
    
    
92. REN F, Zhao S, He X, Lo H, et al
    Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription.
    J Med Virol. 2024;96:e29669.
    PubMed     Abstract available
    
    
    
93. CHANG YP, Huang CB, Su TH, Liu CJ, et al
    Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.
    J Med Virol. 2024;96:e29686.
    PubMed     Abstract available
    
    
    April 2024
94. ZHANG Y, Yuan X, Wang J, Han M, et al
    TRPV4 promotes HBV replication and capsid assembly via methylation modification of H3K4 and HBc ubiquitin.
    J Med Virol. 2024;96:e29510.
    PubMed     Abstract available
    
    
    
95. 
    Retraction: "Small Interfering RNA Effectively Inhibits Protein Expression and Negative Strand RNA Synthesis From a Full-Length Hepatitis C Virus Clone".
    J Med Virol. 2024;96:e29574.
    PubMed     Abstract available
    
    
    
96. JIANG B, Wang L, Liu H, Wang L, et al
    Association of HBV serological markers with host antiviral immune response relevant hepatic inflammatory damage in chronic HBV infection.
    J Med Virol. 2024;96:e29569.
    PubMed     Abstract available
    
    
    
97. CHEN L, Tao X, Zeng M, Li Y, et al
    Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
    J Med Virol. 2024;96:e29613.
    PubMed     Abstract available
    
    
    
98. HOU L, Zhao J, Cai L, Jin L, et al
    HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase.
    J Med Virol. 2024;96:e29607.
    PubMed     Abstract available
    
    
    March 2024
99. CHEN X, Dong S, Shi Y, Wu Z, et al
    Biosensor-based multiple cross displacement amplification platform for visual and rapid identification of hepatitis C virus.
    J Med Virol. 2024;96:e29481.
    PubMed     Abstract available
    
    
    
100. WANG LT, Chen YH, Cheng Y, Fan HL, et al
     Clinical implications of hepatitis B virus core antigen-mediated immunopathologic T cell responses in chronic hepatitis B.
     J Med Virol. 2024;96:e29515.
     PubMed     Abstract available
     
     
     
101. YANG J, Xu S, Cheng J, Yin X, et al
     CXCL10 and its receptor in patients with chronic hepatitis B and their ability to predict HBeAg seroconversion during antiviral treatment with TDF.
     J Med Virol. 2024;96:e29516.
     PubMed     Abstract available
     
     
     
102. CHEN J, Shen L, Guo Q, Ma S, et al
     The downregulation of Tapasin in dendritic cell regulates CD8(+) T cell autophagy to hamper hepatitis B viral clearance in the induced pluripotent stem cell-derived hepatocyte organoid.
     J Med Virol. 2024;96:e29546.
     PubMed     Abstract available
     
     
     
103. ZHA G, Chen Z, Wu N, Huang T, et al
     Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.
     J Med Virol. 2024;96:e29548.
     PubMed     Abstract available
     
     
     
104. MIUMA S, Miyaaki H, Ichikawa T, Matsuzaki T, et al
     Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.
     J Med Virol. 2024;96:e29432.
     PubMed     Abstract available
     
     
     
105. ZHANG H, Li M, Liu H, Dong Y, et al
     Juveniles, young adults, and infants with hepatitis B virus infection: A genomic study.
     J Med Virol. 2024;96:e29530.
     PubMed     Abstract available
     
     
     February 2024
106. GUO L, Liu JJ, Long SY, Wang PY, et al
     TIM22 and TIM29 inhibit HBV replication by up-regulating SRSF1 expression.
     J Med Virol. 2024;96:e29439.
     PubMed     Abstract available
     
     
     
107. CHEN B, Xu B, Cui HY, Ma ZH, et al
     Comparison of effectiveness and cost of different HCV testing strategies in high-risk populations in China.
     J Med Virol. 2024;96:e29433.
     PubMed     Abstract available
     
     
     
108. LU X, Li W, Deng R, Zhou B, et al
     Serum hepatitis B virus spliced RNA proportion increases with liver disease progression in patients with chronic hepatitis B.
     J Med Virol. 2024;96:e29400.
     PubMed     Abstract available
     
     
     
109. LIU W, Li L, Yin M, Cao C, et al
     High-speed centrifugation rather than Lipoclear reagent can be used for removing the interference of lipemia on serological tests of infectious diseases: AIDS, hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle immunoassay.
     J Med Virol. 2024;96:e29385.
     PubMed     Abstract available
     
     
     
110. BLANCO S, Castro GM, Sicilia PE, Carrizo LH, et al
     Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An emerging threat for transfusion safety in low-endemic countries?
     J Med Virol. 2024;96:e29463.
     PubMed     Abstract available
     
     
     
111. LIU Y, Kim ES, Guo H
     Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures.
     J Med Virol. 2024;96:e29485.
     PubMed     Abstract available
     
     
     January 2024
112. SU YP, Lin SY, Su IJ, Kao YL, et al
     Characterization of integrated hepatitis B virus DNA harboring pre-S mutations in hepatocellular carcinoma patients with ground glass hepatocytes.
     J Med Virol. 2024;96:e29348.
     PubMed     Abstract available
     
     
     
113. LI M, Wei Z, Su J, Wu X, et al
     Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China.
     J Med Virol. 2024;96:e29405.
     PubMed     Abstract available
     
     
     
114. ADHIKARI A, Abayasingam A, Brasher NA, Kim HN, et al
     Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes.
     J Med Virol. 2024;96:e29381.
     PubMed     Abstract available
     
     
     
115. PARK K, Kim J, Noh J, Kim K, et al
     First detection and characterization of hepatitis E virus (Rocahepevirus ratti) from urban Norway rats (Rattus norvegicus) in the Republic of Korea.
     J Med Virol. 2024;96:e29401.
     PubMed     Abstract available
     
     
     
116. SHI J, Wang X, Qi W, Wang S, et al
     Association between NTCP hepatic expression and inflammation/fibrosis as well as gender-specific differences in chronic HBV-infected patients.
     J Med Virol. 2024;96:e29428.
     PubMed     Abstract available
     
     
     December 2023
117. PI Y, Li Y, Yan Q, Luo H, et al
     SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1alpha.
     J Med Virol. 2023;95:e29254.
     PubMed     Abstract available
     
     
     
118. ABDEL-SAMIEE M, Youssef MI, Elghamry F, Bazeed M, et al
     A multicentric and nationwide predictive study role of T cell sub-population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients.
     J Med Virol. 2023;95:e29248.
     PubMed     Abstract available
     
     
     
119. LIANG YJ, Chiou YW, Chiu AP, Shiao MS, et al
     Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122.
     J Med Virol. 2023;95:e29325.
     PubMed     Abstract available
     
     
     
120. NGARI JW, Leumi S, Han L, Liu C, et al
     Identification and characterization of Sofosbuvir-resistant mutations of hepatitis C virus genotype 3a replicon.
     J Med Virol. 2023;95:e29290.
     PubMed     Abstract available
     
     
     
121. NUERMAIMAITI A, Chang L, Yan Y, Sun H, et al
     The role of sex hormones and receptors in HBV infection and development of HBV-related HCC.
     J Med Virol. 2023;95:e29298.
     PubMed     Abstract available
     
     
     November 2023
122. KRUMBHOLZ A, Marcic A, Valentin M, Schemmerer M, et al
     Hepatitis A outbreak in a refugee shelter in Kiel, northern Germany.
     J Med Virol. 2023;95:e29185.
     PubMed     Abstract available
     
     
     
123. LI W, Zhang H, Ren A, Fan W, et al
     Systemic lupus erythematosus is associated with lower risk of hepatitis B virus infection: A multivariable Mendelian randomization study in East Asian population.
     J Med Virol. 2023;95:e29226.
     PubMed     Abstract available
     
     
     
124. WANG C, Zhang S, Zhao J, Wang M, et al
     Changes and gaps of global and regional disease burden of hepatitis B infection in children younger than 5 years old between 2015 and 2019: A real-world data review.
     J Med Virol. 2023;95:e29241.
     PubMed     Abstract available
     
     
     
125. LIM CK, Romeo O, Tran BM, Flanagan DJ, et al
     Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids.
     J Med Virol. 2023;95:e29232.
     PubMed     Abstract available
     
     
     October 2023
126. FU MX, Simmonds P, Andreani J, Baklan H, et al
     Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors.
     J Med Virol. 2023;95:e29144.
     PubMed     Abstract available
     
     
     
127. WU WJ, Lin CL, Liu CJ, Huang YW, et al
     Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
     J Med Virol. 2023;95:e29138.
     PubMed     Abstract available
     
     
     
128. LIU J, Zhang H, Kong J, Liu S, et al
     Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control.
     J Med Virol. 2023;95:e29173.
     PubMed     Abstract available
     
     
     
129. ZHANG M, Chen S, Wu X, Zhou J, et al
     Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infection.
     J Med Virol. 2023;95:e29156.
     PubMed     Abstract available
     
     
     
130. ZHAN Y, Tao Q, Lang Z, Lin L, et al
     Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients.
     J Med Virol. 2023;95:e29157.
     PubMed     Abstract available
     
     
     
131. ELIZALDE MM, Giadans CG, Campos RH, Flichman DM, et al
     Impact of core protein naturally selected mutants associated with HBeAg-negative status in HBV biosynthesis.
     J Med Virol. 2023;95:e29195.
     PubMed     Abstract available
     
     
     
132. REN H, Chen X, Wang J, Chen Y, et al
     Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma.
     J Med Virol. 2023;95:e29187.
     PubMed     Abstract available
     
     
     
133. YANG D, Zou J, Guan G, Feng X, et al
     The A1762T/G1764A mutations enhance HBV replication by alternating viral transcriptome.
     J Med Virol. 2023;95:e29129.
     PubMed     Abstract available
     
     
     
134. TANG L, Li Q, Chen L, Li X, et al
     IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection.
     J Med Virol. 2023;95:e29142.
     PubMed     Abstract available
     
     
     September 2023
135. SHEN Z, Zhang S, Jiang Q, Liu N, et al
     Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.
     J Med Virol. 2023;95:e29062.
     PubMed     Abstract available
     
     
     
136. PENG X, Shi Y, Zhang B, Xu C, et al
     Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma.
     J Med Virol. 2023;95:e29084.
     PubMed     Abstract available
     
     
     
137. SUZUKI T, Matsuura K, Watanabe T, Matsui T, et al
     Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance.
     J Med Virol. 2023;95:e29109.
     PubMed     Abstract available
     
     
     
138. LIU C, Guo M, Han L, Lu J, et al
     Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance.
     J Med Virol. 2023;95:e29103.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.